4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001493152-26-006831
CEO, CFO sold 3,896 shares at $1.75 ($6,818)
- CEO, CFO acquired 13,333 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Finley John David CEO, CFO | 2026-02-11 | Option exercise | +13,333 | 31,249 | D: show line 1 in the form | ||
| Finley John David CEO, CFO | 2026-02-12 | Sale | −3,896 | $1.75 | $6,818 | 27,353 | D: show line 2 in the form |
| Open-market sales · 3,896 sh · avg $1.75 · $6,818 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Finley John David CEO, CFO | 2026-02-11 | Option exercise · Restricted Stock Units | −13,333 | 26,667 | D: show line 3 in the form |
Loading xslF345X05/ownership.xml…